DEMONSTRATION OF ANTIBODIES AGAINST MYCOPLASMA PNEUMONIAE IN BRONCHIAL SECRETIONS BY IMMUNOFLUORESCENCE *

G. Biberfeld,G. Sterner

DOI: https://doi.org/10.1111/j.1749-6632.1971.tb35029.x

IF: 6.499

1971-06-01

Annals of the New York Academy of Sciences

Abstract:Mycoplasma pneumoniae, formerly called the primary atypical pneumonia agent, is an important respiratory pathogen in man.' Before this agent had been identified as a mycoplasma, the immunofluorescence (IFL) technique was for several years the only practically useful method for the demonstration of antibodies to this microorganism.* At that time the antigen used in the IFL test consisted of frozen sections of bronchi from chick embryos infected with the agent. Later, when the organism could be cultivated on agar, it became possible to use colonies of M. pneumoniae transferred to glass slides as antigen in the IFL test.3 However, other less laborious techniques such as complement fixation (CF), indirect hemagglutination, and metabolic or tetrazolium reduction inhibition are now commonly used for the demonstration of serum antibodies to M. pneumniae.' For the investigation of M. pneumoniae antibodies in bronchial secretions, we chose the IFL technique since this method measures antibodies of all the three main immunoglobulin classes and permits the determination of the immunoglobulin class of the antibodies without previous fractionation of the specimens.